Diabetic Retinopathy and Pregnancy in Type 1 Diabetes Mellitus: A Non Systematic Evidence Based Review


avatar KS Aljabri 1 , * , avatar DM Thompson 2

Division of Endocrinology & Department of Medicine, King Fahad Armed Forces Hospital, khalidsaljari@yahoo.com, Kingdom of Saudi Arabia
Division of Endocrinology, Vancouver Hospital,University of British Columbia, British Columbia, Canada

how to cite: Aljabri K, Thompson D. Diabetic Retinopathy and Pregnancy in Type 1 Diabetes Mellitus: A Non Systematic Evidence Based Review. Int J Endocrinol Metab. 2007;5(3): 149-159. 


World-wide it is estimated that over 2.5 million peo-ple are blind due to diabetes mellitus. The exact pathogenesis of diabetic retinopathy is not fully un-derstood. Some factors may act simultaneously in the pathogenesis diabetic retinopathy. Although ma-jor advances in the clinical diagnosis and treatment of diabetic retinopathy and its associated complica-tions have been achieved over the past 5 decades, diabetic retinopathy remains the leading cause of new blindness among working-age coincides with peak fertility and childbearing years, individuals in developed countries. Understanding the risk factors that may lead to progression among diabetic women in pregnancy is of great important in the manage-ment of diabetic retinopathy. Patients who are in good glucose control at the start of pregnancy and who maintain tight control during pregnancy have little risk of progression of retinopathy. Slowing the progression of retinopathy and reducing visual loss in pregnancy seems to be by the use of laser photo-coagulation before pregnancy.

Full Text

Full text is available in PDF

© 0, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.